Respiratory disease and cardiovascular morbidity

Occupational and Environmental Medicine

Volumn 62, Issue 9, 2005, Pages 650-655

  Koskela, R S ^a   Mutanen, P ^a   Sorsa, J A ^a   Klockars, M ^b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC BRONCHITIS; COMORBIDITY; COTTON; DUST EXPOSURE; ELECTRIC ACTIVITY; FOUNDRY; GRANITE; HUMAN; IRON AND STEEL INDUSTRY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METAL INDUSTRY; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; STATISTICAL ANALYSIS; UPPER RESPIRATORY TRACT INFECTION;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COHORT STUDIES; CONSTRUCTION MATERIALS; DUST; FINLAND; HUMANS; MALE; METALLURGY; MINING; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RESPIRATION DISORDERS; RISK FACTORS; TEXTILE INDUSTRY;

GOSSYPIUM HIRSUTUM;

EID: 24044467101     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2004.017111     Document Type: Article

References (44)

1. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-20.
2. Muhlstein JB, Andersson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
3. Nieto FJ. Infections and atherosclerosis: new clues from an old hypothesis. Am J Epidemiol 1998;148:937-48.
4. Weissberg PL. Atherogenesis: current understanding of the causes of atheroma. Heart 2000;83:247-52.
5. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
6. Hendrix MG, Salimans MM, van Boven CP, et al. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990;136:23-8.
7. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;11:983-5.
8. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
9. Spodick DH, Flessas AP, Johnsson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984;53:481-2.
10. Mattila KJ. Viral and bacterial infections in acute myocardial infarction. J Intern Med 1989;225:293-6.
11. Jousilahti P, Vartiainen E, Tuomilehto J, et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996;348:567-72.
12. Koskela R-S, Klockars M, Järvinen E, et al. Mortality and disability among granite workers. Scand J Work Environ Health 1987;13:18-25.
13. Koskela R-S. Association of silica dust exposure with lung cancer and other diseases [dissertation]. University of Tampere, Tampere, 1995 (Acta Universitatis Tamperensis, ser A, vol. 460).
14. Koskela R-S, Hernberg S, Kärävä R, et al. A mortality study of foundry workers. Scand J Work Environ Health 1976;2(suppl 1):73-89.
15. Koskela R-S, Mutanen P, Sorsa J-A, et al. Factors predictive of ischemic heart disease mortality in foundry workers exposed to carbon monoxide. Am J Epidemiol 2000;152:628-32.
16. Koskela R-S, Klockars M, Järvinen E. Mortality and disability among cotton mill workers. Br J Ind Med 1990;47:384-91.
17. Koskela R-S. Mortality, morbidity and health selection among metal workers. Scand J Work Environ Health 1997;27(suppl 2):1-80.
18. National Board of Health. Tauti- ja kuolinsyyluokitus [The WHO international statistical classification of diseases, injuries and causes of death]. Helsinki, Finland: National Board of Health, 1969.
19. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva: World Health Organization, 1968.
20. Huhti E. Prevalence of respiratory symptoms, chronic bronchitis and pulmonary emphysema in a Finnish rural population. Acta Tuberc Scand 1965;61:(suppl LXI).
21. Medical Research Council's Committee on the Aetiology of Chronic Bronchitis. Standardized questionnaires on respiratory symptoms. BMJ 1960;2:1665.
22. Medical Research Council's Committee on the Aetiology of Chronic Bronchitis. Instructions for the use of the questionnaire on respiratory symptoms. London: British Research Council, 1960.
23. Medical Research Council's Committee on the Aetiology of Chronic Bronchitis. Definition and classification of chronic bronchitis. Lancet 1965;1:775-9.
24. Breslow NE, Day NE, Heseltine E, eds. Statistical methods in cancer research. The design and analysis of cohort studies. Vol. II. IARC Scientific Publications no. 82. Lyon: International Agency for Research on Cancer, 1987.
25. Cox DR. Regression models and life tables (with discussion). J R Soc Stat B 1972;34:187-220.
26. Peters A, Döring A, Wichmann HE, et al. Increased plasma viscosity during air pollution episode: a link to mortality? Lancet 1997;349:1582-7.
27. Peters A, Dockery DW, Muller JE, et al. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001;103:2810-15.
28. Samet JM, Dominici F, Curriero FC, et al. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 2000;343:1742-9.
29. Nemmar DVM, Hoet P, Vanquickeborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation 2002;105:411-14.
30. Pope CA III, Verrier RL, Lovett EG, et al. Heart rate variability associated with particulate air pollution. Am Heart J 1999;138:890-9.
31. Finkelstein JN, Johnston G, Barrett T, et al. Particulate-cell interactions and pulmonary cytokine expression. Environ Health Perspect 1997;105(suppl 5):1179-82.
32. Driscoll KE, Carter JM, Hassenbein DG, et al. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect 1997;105(suppl 5):1159-64.
33. Seaton A, MacNee W, Donaldson K, et al. Particulate air pollution and acute health effects. Lancet 1995;345:176-8.
34. Kärävä R, Hernberg S, Koskela R-S, et al. Prevalence of pneumoconiosis and chronic bronchitis in foundry workers. Scand J Work Environ Health 1976;2(suppl 1):64-72.
35. Koskela R-S. Cardiovascular diseases among foundry workers exposed to carbon monoxide. Scand J Work Environ Health 1994;20:286-93.
36. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study. Circulation 2001;103:1064-70.
37. Keaney JF, Vita JA. The value of inflammation for predicting unstable angina. N Engl J Med 2002;347:55-7.
38. Laurila A, Bloigu A, Näyhä S, et al. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arteriosclerosis Thrombosis Vasc Biol 1997;17:2910-13.
39. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
40. Wilson R. Evidence of bacterial infection in acute exacerbations of chronic bronchitis. Semin Respir Infect 2000;15:208-15.
41. Niroumand M, Grossman RF. Airway infection. Infect Dis Clin North Am 1998;12:671-88.
42. Read RC. Infection in acute exacerbations of chronic bronchitis: a clinical perspective. Respir Med 1999;93:845-50.
43. Ridker PM, Cushman M, Stamfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
44. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.